Sapna Patel @DrSapnaPatel Twitter profile

Last Seen Profiles

@Prof_Farzad_WLV

@cnewmannews

@MyronNelso45103

@Ammutube

@tjgotemmcoach

@ABaird2008

@0lfr_

@ishootboys

@gaydentists

@marwanrr

@ChemBark

@Phase_R

@FT_FANCLUB

@yungtero

@karchnaval

@powell_mani

@EPoventud

@sfvEDtech

@TDAndrews4

@omarshaya

@iznovaa

@grtdrank

@wpgraphql

@NutmegNews

@AHoensbroech

@k_myon_RPS13

@mannu_meha

@phenod

@Han652297732768

@PonyRosaaa

@MHG_Int

@nilanmorton

@bod_republic

@insomniacgames

@Parlons_PP

@Donald_Driver80

Sapna Patel

@DrSapnaPatel

1 year

It's here and... waited for all embargoes to be lifted ... #neoadjuvant #melanoma @SWOG #S1801 callback to @myESMO tag #neoadjuvant é 😉 A great team effort @SWOG , @NCICTEP_ClinRes , NCTN, NCORPs - & ‼️ example of how cooperative groups can succeed! 💫

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma | NEJM

Whether pembrolizumab given both before surgery (neoadjuvant therapy) and after surgery (adjuvant therapy), as compared with pembrolizumab given as adjuvant therapy alone, would increase event-free...

www.nejm.org

16

41

189

Sapna Patel

@DrSapnaPatel

4 months

🎄 Christmas weekend rounds, a morning hospital selfie a la @doctorpemm in front of grand @MDAndersonNews

12

8

125

Sapna Patel

@DrSapnaPatel

3 years

It's my honor to assume this role for @SWOG @SWOGChair and @MDAndersonNews as disease site chair for #Melanoma #melsm

SWOG Cancer Research Network

@SWOG

3 years

Our @SWOGChair blog: Mariana Chavez Mac Gregor, MD, MSc, is our new executive officer for international affairs, & Sapna P. Patel, MD, is incoming melanoma committee chair! @DrSapnaPatel New Leadership for @SWOG International Affairs and Melanoma Research

1

8

22

5

109

Sapna Patel

@DrSapnaPatel

3 years

Out study is finally out - it didn't feel apropos to tweet this last week with other important matters top of mind. Phase 2 Study Finds Nivolumab-Ipilimumab Combo Shows Activity in Metastatic #UvealMelanoma @ASCO #JCO

Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study

PURPOSE Metastatic uveal melanoma has poor overall survival (OS) and no approved systemic therapy options. Studies of single-agent immunotherapy regimens have shown minimal benefit. There is the...

ascopubs.org

6

15

83

Sapna Patel

@DrSapnaPatel

2 years

Smiles and butterflies - #ESMO22 Paris pre-session photo of the bearers of good news #ChalabiPlot and #S1801 - #neoadjuvant 📸 @KKronig , thank you 🙏🏽 ( #neoadjuvant é @OlofssonBagge , best meme of the mtg!)

2

8

74

Sapna Patel

@DrSapnaPatel

4 months

Holiday rounds complete ✅ ✨ Peaceful, healthy holidays to everyone ❤️ Handing off to @tcellsrus @MDAndersonNews 🧑‍🎄 🎅 🎄 #pemmselfie

3

6

69

Sapna Patel

@DrSapnaPatel

2 years

Simple study, sequence is the only difference that improved outcomes! @myESMO #ESMO22 @SWOG @MDAndersonNews #melsm #neoadj

MD Anderson Cancer Center

@MDAndersonNews

2 years

#ESMO22 Abstract LBA6: Our Dr. Sapna Patel presents data supporting neoadjuvant immunotherapy for patients with high-risk melanoma. “It's not just what you give, it's when you give it,” Patel says: @DrSapnaPatel @SWOG #ESMO22 #EndCancer

2

6

16

1

7

57

Sapna Patel

@DrSapnaPatel

6 months

Thank you @myESMO for another fantastic scientific program #ESMO23 in Madrid.. we continue to learn from the @SWOG #S1801 exploratory endpoints for #neoadjuvant therapy in #melanoma

0

5

48

Sapna Patel

@DrSapnaPatel

6 months

✨A beautiful night @delcoronado for #SITC2023 Academy gala with friends #endcancer @sitcancer

4

46

Sapna Patel

@DrSapnaPatel

6 months

My #ESMO23 highlights include speaker ready room run-ins with these fantastically photogenic colleagues @myESMO @OmidHamidMD

5

9

46

Sapna Patel

@DrSapnaPatel

6 months

. @taylorswift13 my Rio day so far... pool time prepping for a webinar 🖥 then red lip classic💄 followed by sparkle practice ✨️- see you in this jacket on Saturday! Ps - hope you are tickled by my OOO homage 🫶🏽

3

0

43

Sapna Patel

@DrSapnaPatel

2 years

A kind moment to pause and remember a graceful colleague by @DrChoueiri at #ESMO2022 in the Presidential Symposium who took cabozantinib from #METEOR to #COSMIC in 7 years from the same stage @myESMO

0

7

43

Sapna Patel

@DrSapnaPatel

8 months

Thank you @jitcancer for highlighting this cool immune toxicity prediction work - haplotypes segregate those who may be protected from irAEs. Congrats to the affable and always amiable @ANaingMD - so glad to be your colleague and collaborator @MDAndersonNews

Journal for ImmunoTherapy of Cancer

@jitcancer

9 months

New #JITC article: T-cell receptor beta variable gene polymorphism predicts immune-related adverse events during checkpoint blockade immunotherapy @DrSapnaPatel @ANaingMD

2

55

81

0

13

41

Sapna Patel

@DrSapnaPatel

2 years

IF 1000.00

Vivek Subbiah, MD

@VivekSubbiah

2 years

💫At the Presidential Dinner @myESMO #ESMO22 @DrChoueiri @DrSapnaPatel @MyriamChalabi @OncoAlert ! What is the impact factor of this tweet ?

8

210

0

3

40

Sapna Patel

@DrSapnaPatel

2 years

Was in clinic yesterday seeing uveal melanoma patients so was not able to stop and comment but what a *big big big* day for rare cancers - #KIMMTRAK approval for metastatic #uveal #melanoma Congratulations to all involved $IMCR First #TCR therapeutic approved in oncology! (1/4)

1

6

40

Sapna Patel

@DrSapnaPatel

4 years

Going to work in scrubs for the first time in over a decade. All sorts of feels. #medtwitter #FlattenTheCurve

7

4

39

Sapna Patel

@DrSapnaPatel

4 months

🔹��Reflecting on a peaceful week and safe December on call for @MDAndersonNews 🎶 🔹️Grateful for spectacular inpatient and ambulatory team camaraderie 🎵 🔹️"You'll be Santa Claus and I'll be Mrs..."

3

38

Sapna Patel

@DrSapnaPatel

1 year

Thank you to Prof Shackleton and @MASC_Trials for the lovely meeting and invitation to share what we are doing @SWOG #Melanoma Cmte

Melanoma and Skin Cancer Trials (MASC Trials)

@MASC_Trials

1 year

The 2023 MASC Trials Annual Science Meeting has begun, opened by international keynote speaker @DrSapnaPatel presenting on @SWOG melanoma trials in the USA.

0

1

23

1

2

38

Sapna Patel

@DrSapnaPatel

6 months

2 year recurrence free survival benefit for resectable #melanoma treated with #neoadjuvant /adjuvant pembrolizumab - results described by pathologic response @SWOG #S1801 study @ecancer @myESMO @OncoAlert

2 year recurrence free survival benefit for resectable melanoma treated with neoadjuvant/adjuvant...

Dr Sapna Patel speaks to ecancer at ESMO 2023 about the SWOG S1801 study which was for resectable stage 3 or stage 4 melanoma patients. They were randomised

ecancer.org

0

11

38

Sapna Patel

@DrSapnaPatel

2 months

An amazing day @WinshipAtEmory Melanoma & Cutaneous Malignancy Symposium 🍑 Thank you @RamalingamMD for opening remarks @MichaelCLoweMD & David Lawson & Melinda Yushak for the invitation 🍑 @Chrystal_Paulos & @LesinskiLab for attendance 🍑 Nicole Kounalakis Jacob Choi et al

Chrystal Paulos

@Chrystal_Paulos

2 months

Wonderful talk by the amazing Dr. Sapna Patel @DrSapnaPatel at our melanoma symposium @WinshipAtEmory : Updates in neoadjuvant therapies on advanced resectable melanoma.

4

2

33

3

2

37

Sapna Patel

@DrSapnaPatel

2 years

📰🗣️ @SWOG #S1801 : Neoadjuvant Pembrolizumab Improves Event-Free Survival in Stage III-IV Melanoma @ASCO Daily News #frontpage #readallaboutit #neoadjuvant #melanoma #melsm 🗞️ 🤳 @NCICancerTrials @EladSharonMD - THANK YOU 🧵 (1/4)

SWOG S1801: Neoadjuvant Pembrolizumab Improves Event-Free Survival in Stage III-IV Melanoma

Results from the phase 2 SWOG S1801 trial showed that neoadjuvant pembrolizumab led to better event-free survival (EFS) compared with adjuvant pembrolizumab.

dailynews.ascopubs.org

1

12

33

Sapna Patel

@DrSapnaPatel

1 year

Desmoplastic #melanoma *off the charts* literally (look top right of slide by AACR logo) by Dr Zeynep Eroglu - S1512 Dr Kari Kendra highest solid tumor ORR in unresectable / metastatic disease!! Congratulations 🎊 @SWOG @NCICTEP_ClinRes @EladSharonMD @ToniRibas12 @CampKatiee ‼️

2

13

34

Sapna Patel

@DrSapnaPatel

6 months

✨Laudatory introduction by Iman Osman @Perlmutter_CC for @mcquadeMDLAc and her work on diet, microbiome, & weight ⚖️ as it relates to #melanoma @SocietyMelanoma #SMR23 - a great talk and a ton of work to do this in patients #feeding #diet 💫

0

9

33

Sapna Patel

@DrSapnaPatel

10 months

Highlight of my past 2 weeks in pics.. 💞 @ninashah33 @DrKrinaPatel @doctorpemm @VivekSubbiah (for you, @DrChoueiri ). Despite A/C going out 2x 🥵, ➡️ new HVAC system🫣, life is good and human and four-legged connections leave me 🫶🏽🫂 #ChewyPatel

0

4

32

Sapna Patel

@DrSapnaPatel

2 years

@DrChoueiri @SWOG @myESMO @OncoAlert @PGrivasMDPhD @TiansterZhang @DrRanaMcKay @urotoday @kidneycan @montypal @DanaFarber_GU @MDAndersonNews I received a twitter shoutout from @DrChoueiri ?!?! Does this mean I’m in the same category as football clubs? I’m faint … @SWOG #S1801 @NCICTEP_ClinRes 😀

2

1

32

Sapna Patel

@DrSapnaPatel

10 months

Listen friends, I fell in love today...💓 my beautiful friend's beautiful dogs 🐾🐕 #heaven MD Anderson connections are strong 💪🏽 Thank you @ClevelandClinic for the invitation (and excuse) to snuggle these fur muffins ❤️

3

0

31

Sapna Patel

@DrSapnaPatel

2 years

A great @SWOG Spring meeting last week in #Seattle with excellent #melanoma committee meetings

1

0

31

Sapna Patel

@DrSapnaPatel

5 months

🎊 Beautiful & visual experience in #Singapore for (my 1st) #ESMOAsia23 🎊 Gratitude to co-chair Prof Han Chong Toh, D Dir @nccsingapore & @ajsfurness @royalmarsdenNHS 🎊 special thank you to @myESMO Prez-Elect @FAndreMD for the airport lift and lovely conversation😊

0

2

30

Sapna Patel

@DrSapnaPatel

2 years

@SWOG @myESMO - honored, excited ... and nervous to be presenting at the Presidential Symposium!! 👩🏽‍🔬 Looking forward to sharing the results of #S1801 with everyone next week📸 @MDAndersonNews @NCICTEP_ClinRes #melanoma #melsm

Omid Hamid MD

@OmidHamidMD

2 years

#Neoadjuvant spotlight #ESMO22 @SWOG 1801 Melanoma @DrSapnaPatel LBA6 - Neoadjvuant versus adjuvant pembrolizumab for resected stage III-IV melanoma (SWOG S1801) This will bring NA into the spotlight AGAIN globally @myESMO

0

5

26

0

7

29

Sapna Patel

@DrSapnaPatel

2 years

As I unpack from #ESMO22 I share my week in 📸 @myESMO President @peters_solange thank you for the stellar✨ scientific program chaired by @FAndreMD @CharlesSwanton , the impressive release of data, the opportunity to meet-n-tweet so many colleagues in oncology @OncoAlert 🧵(1/17)

0

2

30

Sapna Patel

@DrSapnaPatel

4 years

Mixing it up today wearing scrubs from back in the day. Thank you @utmbhealth SOM 2005 for this student-issued pair 15 years ago. Dog remains unimpressed. #COVID19 #FlattenTheCurve #medtwitter

4

0

27

Sapna Patel

@DrSapnaPatel

6 months

Monday morning nerves felt better with great colleagues and support in the @myESMO #ESMO23 speaker ready room @VivekSubbiah @GlitzaMDPhD before the #melanoma orals

0

4

29

Sapna Patel

@DrSapnaPatel

2 years

I don't know how I missed this clever and catchy tweet yesterday @OlofssonBagge 😁 let's make it hashtag #neoadjuvant é #S1801 @SWOG @NCICTEP_ClinRes

Roger Olofsson Bagge

@OlofssonBagge

2 years

@DrSapnaPatel Congratulations! You started a new French Revolution today! Liberté, égalité, fraternité et neoadjuvanté

0

2

6

1

3

26

Sapna Patel

@DrSapnaPatel

2 years

More grabs from #S1801 #ESMO22 presentation, thank you @AnkitmanglaMD for the photo and your participation in the study! @myESMO (6/17)

1

4

27

Sapna Patel

@DrSapnaPatel

9 months

So happy to see this Summer program continue to excel @MDAndersonNews #uvealmelanoma #liquidbiopsy Abdulkader Almosa rising star 💫 college gem 💎

0

2

27

Sapna Patel

@DrSapnaPatel

2 years

My farewell #ESMO22 tweet from CDG includes a session from Monday with Pres @peters_solange on liquid biopsies, and a selfie with the incomparable indefatigable @myESMO programme team @KKronig @FedefedeFri also shoutout to🗣 @SimonaTe286 @DebbyCarboAsta - incredible support!!👏🏼🙏🏽

2

26

Sapna Patel

@DrSapnaPatel

1 year

Bravo Kari Kendra and @SWOG @NCICTEP_ClinRes @EladSharonMD and all participants and investigators on S1512 - unresectable desmoplastic #melanoma showing huge ORR to single-agent pembro!!

0

7

27

Sapna Patel

@DrSapnaPatel

2 years

Thank you for the Wolfpack love 💗 @HemOncWomenDocs

Allison Betof Warner, MD, PhD

@DrBetofMDPhD

2 years

Our #WomenInMelanoma group (ring-led by @AIMatMelanoma ) turned out to support @DrSapnaPatel discussion S1801 #neoadjuvant vs #adjuvant Pembro for stage III/IV melanoma.

3

1

35

2

1

27

Sapna Patel

@DrSapnaPatel

2 years

To have the renowned @DrChoueiri reference @SWOG #S1801 study in this way as one of the most impactful at #ESMO22 is an honor!! He is humbly omitting his Triplet regimen in #COSMIC -313 which had a strong signal in intermediate-risk RCC✨️ @myESMO @theNCI #neoadjuvant #melsm

Toni Choueiri, MD

@DrChoueiri

2 years

One of the most impactful studies to be presented #ESMO22 was the one by Dr @DrSapnaPatel —neoadjuvant approaches with IO! Of course, there is also the #ChalabiPlot @MyriamChalabi @myESMO @OncoAlert

2

6

56

0

3

26

Sapna Patel

@DrSapnaPatel

2 years

Witnessed one of the best @montypal do what he does… command a room at #ESMO22 … eloquently discuss data, and then swoon at his humility on @Twitter afterwards (15/17)

1

4

26

Sapna Patel

@DrSapnaPatel

2 years

#ESMO22 Presidential Dinner in a historic setting with memorable people @myESMO @VivekSubbiah @DrChoueiri @MyriamChalabi @peters_solange @FAndreMD @CharlesSwanton (12/17)

0

3

25

Sapna Patel

@DrSapnaPatel

2 years

@MyriamChalabi @BenWestphalen @JenSeligmann @FilippoPietran4 What @MyriamChalabi said! Spot on, so right. We see the names, faces, and stories behind the data in our trials…we think of them at night, in the mornings, on our days off… brainstorming to improve outcomes, unsatisfied with status quo… striving for the #ChalabiPlot 🏥🏆

1

0

24

Sapna Patel

@DrSapnaPatel

9 months

Engaged and leaning in for this talk @AIMatMelanoma #WIM meeting on “Disenfranchised grief” by @MollyVocino from @TJUHospital @KimmelCancerCtr Trajectory of #grief , grief v trauma, over-pathologizing grief

1

4

24

Sapna Patel

@DrSapnaPatel

3 years

@DocPriteshPatel actually didn’t take me 5” to read… but it has stayed with with me for 2 days ❤️‍🩹💔 Printed it for nurse practitioners to read this wkd on rounds. Last line of main essay…haunting. Your #oncology tribe surrounds & supports u💞 tho it cannot erase @ASCO_pubs

Pritesh Patel

@DocPriteshPatel

3 years

If you treat cancer and have 5 minutes to spare, read about my little boy💔 #JCO @ASCO_pubs #btsm My Beautiful Boy | Journal of Clinical Oncology

286

710

2K

0

2

23

Sapna Patel

@DrSapnaPatel

5 years

Front page above the fold! ⁦ @ERPlimackMD ⁩ 🎉🎉📰

1

3

24

Sapna Patel

@DrSapnaPatel

5 years

We do white! On Wear White Day, @MDAndersonNews Melanoma strives for a future #Immune2Cancer @CancerResearch #melsm #endcancer

2

1

22

Sapna Patel

@DrSapnaPatel

2 years

#ESMO22 concludes with the powerhouse team that made it all possible… @myESMO 👑 Pres @peters_solange 👸🏼 & the unfaltering, tireless programme team led by @KKronig @FedefedeFri @SimonaTe286 @DebbyCarboAsta Hope we didn’t make it too hard for you! See you next year! 👋🏽 (17/17)

0

3

22

Sapna Patel

@DrSapnaPatel

6 months

It's not #ESMO22 in Paris, but it was #ESMO23 in Madrid where I managed to capture two of my favorites @DrChoueiri @VivekSubbiah in a Monday morning selfie 🤳 .. never managed to recreate our iconic 2022 photo 📸 but a great alternative 🤩

0

4

23

Sapna Patel

@DrSapnaPatel

3 years

a brilliant walk through why the Delta R0 and Re are a sobering realization that we are nowhere near the end. i love it as a #mathnerd and gave this chalk talk on the white board in clinic to at least 4 patients on Wednesday... @EpiEllie #COVID19 #CovidVaccine

Dr Ellie Murray, ScD

@EpiEllie

3 years

THINK LIKE AN EPIDEMIOLOGIST: The CDC’s recent announcement that the Delta variant has an average reproductive number of 6-9 has a lot of people concerned & many are asking me about whether this means we need COVID boosters. Let’s talk through the math of how we might decide!

282

5K

10K

1

5

21

Sapna Patel

@DrSapnaPatel

2 years

A quick one-hour webinar tonight discussing the utility of liver-directed therapy in the treatment of patients with the rare cancer metastatic #uveal #melanoma @MRFCureOM @CureMelanoma @ACureInSight1 @MelanomaReAlli @RareDiseases

CURE Ocular Melanoma

@MRFCureOM

2 years

Today at 7pm ET for our Ask the Expert series, bring your questions & join a live Zoom discussion on Liver Directed Therapies for Metastatic Uveal Melanoma. The MRF thanks #TriSalus for sponsoring this important educational opportunity! Register here -

0

2

3

0

7

23

Sapna Patel

@DrSapnaPatel

2 years

Successful in-person Cure OM Global Science Meeting Edinburgh, Scotland - 🙏🏽 thank u to all involved incl virtual attendees ⌨️🖱💻 @MRFCureOM @CureMelanoma It's the annual preamble to the @SocietyMelanoma congress Let us know key takeaways & what u want to see / discuss next yr!

0

1

22

Sapna Patel

@DrSapnaPatel

2 years

Proud of Kari Kendra @ToniRibas12 and @SWOG for #ASCO22 oral presentation on S1512 neoadj pembro for desmoplastic #melanoma Discussant called it a "perfect neoadjuvant study" given the high rate of pathologic response #melsm @OSUCCC_James @UCLAJCCC

0

1

20

Sapna Patel

@DrSapnaPatel

11 months

The honor and pride was mutual - to be aside an innovative surgical oncologist @OlofssonBagge and his European #uveal team @ny_lars as well as the famous Jun Guo from Peking U in Beijing. + the ever gracious Rich Carvajal @NorthwellHealth @OncoAlert

Roger Olofsson Bagge

@OlofssonBagge

11 months

Great discussion today @ASCO #ASCO23 on novel treatment for patients with uveal melanoma. Proud to present #SCANDIUM trial and to share the stage with ⁦ @DrSapnaPatel ⁩ presenting TILs therapy!!!

2

39

2

5

21

Sapna Patel

@DrSapnaPatel

11 months

My @ASCO meeting ends with a virtual morning clinic👩🏽‍⚕️from the lovely @WHotels Lake Shore 🏨 hotel room 2719 followed by watching the #melanoma oral session with ⭐️ chairwomanship Pavlick & @DrBetofMDPhD , die hard til the end 🕕 per @BhatiaS_MD @OncoAlert #ASCO23 👏🏽 👩🏽‍💻👩🏻‍🔬👩🏼‍⚕️👨🏽‍⚕️

1

7

21

Sapna Patel

@DrSapnaPatel

2 years

@montypal gives a #masterclass discussing @DrChoueiri LBA #COSMIC -313 in #RCC @myESMO #ESMO2022 @COHMedOnc

1

5

20

Sapna Patel

@DrSapnaPatel

2 years

"F*** CANCER"

2

0

20

Sapna Patel

@DrSapnaPatel

2 years

The feels are real @montypal - we did this w/ the support of amazing @SWOG Ops and Stats team (*lauding* the spectacular Megan Othus) and commitment fr concept to completion of @EladSharonMD and @NCICTEP_ClinRes @myESMO #ESMO22 @MDAndersonNews #S1801 #neoadjuvant from here fwd

Sumanta K. Pal, MD, FASCO

@montypal

2 years

Moments like this make me so proud to be a part of @SWOG ! Huge congrats to @DrSapnaPatel @MDAndersonNews . Data also informative for us in #kidneycancer given recent data from @eaonc #PROSPER presented by @allaf_mo , also at #ESMO22 .

1

9

25

0

2

19

Sapna Patel

@DrSapnaPatel

3 years

Another close of a wonderful #WomenInMelanoma @AIMatMelanoma weekend. So much good stuff discussed that does not show up anywhere on our CV 📄🗃 @FunchainMD @JaniceM10 @ragikudchadkar @MunTheLoon @drdonsdizon @DrBetofMDPhD @SiwenONC @DrJustineCohen @bbuchbinderMD

Pauline Funchain

@FunchainMD

3 years

Good morning 🌞 from the #WomenInMelanoma Best meeting of the year Making diversity happen at our institutions and our fields by supporting #WomenInMedicine Fab guest speaker on medical #SoMe @drdonsdizon And just a great group of humans 🥰 @AIMatMelanoma

1

6

29

1

5

17

Sapna Patel

@DrSapnaPatel

6 months

Thanks @sitcancer for a wonderful #SITC23 meeting and Academy gala 🌟 Congrats to @kmargolin for her lifetime achievement award & FAIO🥇 & shout out to Cayla and the on staff crew who kept things moving seamlessly .. next stop @SocietyMelanoma after an abbreviated Monday clinic

0

19

Sapna Patel

@DrSapnaPatel

4 years

Congrats to my friend @ANaingMD @project_ronin for their free IO Tox management app. This will help with real-time, evidence-based guidance managing immunotherapy toxicities. #endcancer @alexshoushtari @tmprowell @harpreet_md @marklewismd @rachnatshroff @JaniceM10 @evanlipson

0

4

19

Sapna Patel

@DrSapnaPatel

2 years

So many 📸 to share from Presidential Symposium #S1801 presentation - thank you to all who took them @GlitzaMDPhD @DrBetofMDPhD Adi Diab, @EladSharonMD @myESMO #ESMO22 (4/17)

1

2

18

Sapna Patel

@DrSapnaPatel

9 months

🗣️Congrats to Delcath for persistence with this treatment option! Late night waiting for news 📰 🎊Dr. Jon Zager @MoffittNews leading this effort in U.S.🌟 FDA Approves HEPZATO KIT for Hepatic-Dominant Metastatic #Uveal Melanoma via @onclive

FDA Approves HEPZATO KIT for Unresectable Hepatic-Dominant Metastatic Uveal Melanoma

The FDA has approved HEPZATO KIT (melphalan/Hepatic Delivery System) for use in the treatment of select patients with unresectable hepatic-dominant metastatic uveal melanoma.

www.onclive.com

0

2

18

Sapna Patel

@DrSapnaPatel

3 years

Indeed, hats off to friends and colleagues for this great work! @NEJM #goals #uvealmelanoma #melsm

Omid Hamid MD

@OmidHamidMD

3 years

Congrats to @Immunocore for @NEJM publication Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma. Proud to be part of this program and its success for our patients #clinicaltrials @angelesclinic

2

48

165

0

5

18

Sapna Patel

@DrSapnaPatel

5 years

It was my pleasure to be a part of the meaningful symposium @MelanomaReAlli Scientific Retreat

Tracy Callahan

@polkadotmamainc

5 years

@DrSapnaPatel @TeamTJSharpe @LSimmsDC Thanks for discussing the importance of family support as patients navigate the melanoma diagnosis. #skincancer #melanoma #cancer

0

2

6

0

4

17

Sapna Patel

@DrSapnaPatel

5 years

Keepin' it tight, doing it white on Wear White Day! Melanoma Medical Oncology and Research tip their wardrobes for #Immune2Cancer #melsm @MDAndersonNews @CancerResearch #endcancer

1

0

17

Sapna Patel

@DrSapnaPatel

2 years

Such an honor and pleasure to talk to 2 of the best in the biz- @OncBrothers helping all of us makes sense of practice changing data in oncology 📈📉🩺 For a brief review of @SWOG #S1801 , IMMUNED, & SECOMBIT, check out the podcast:

Melanoma ESMO 2022 Highlights - OncBrothers (Rohit and Rahul Gosain)...

Discussing Melanoma ESMO 2022 Highlights - Practice changing studies with Dr. Sapna Patel, Director of Uveal Melanoma, Program Director of Melanoma Fellowshi...

www.youtube.com

Oncology Brothers

@OncBrothers

2 years

#Melanoma #ESMO22 Highlights w/ @DrSapnaPatel for the Community Oncologists. Practice Changing “these 3 studies are ready to go” - #SWOGS1801 - #IMMUNED - #SECOMBIT Full Int. - - #OncTwitter #MedTwitter @SWOG @DrChoueiri

4

12

30

1

3

16

Sapna Patel

@DrSapnaPatel

2 years

@JimAllisonPhD @PamSharmaMDPhD Thank you Jim and Pam for the kind words. We stand on the shoulders of giants (you) to boost outcomes for our patients @SWOG @NCICTEP_ClinRes @MDAndersonNews #S1801 #neoadjuvant #melanoma #melsm

0

1

16

Sapna Patel

@DrSapnaPatel

5 years

@CathyEngMD @disparityreport @viralreact @karenluMD @IshwariaMD @DrEmmaHolliday @JenWargoMD @MDAndersonNews Thank you @CathyEngMD ! Five more women making waves in science are: @rachnatshroff @ninashah33 @ERPlimackMD @DrSGraff @tmprowell

3

2

16

Sapna Patel

@DrSapnaPatel

4 years

A week that started with 5 new clinic patients on Memorial Day ending with a grateful garage photo on friday...grateful to head home feeling well ... optimistic for weekend rounds 😷🤞🏽

1

0

15

Sapna Patel

@DrSapnaPatel

7 months

Teenage mutant ninja tertiles - CD8+ expression in #RELATIVITY047 #melanoma trial . . . Great job Evan Lipson! @myESMO #ESMO2023

0

4

15

Sapna Patel

@DrSapnaPatel

10 months

🌟🎇 From the #Leukemia #GOAT 🐐 himself @DrHKantarjian ... work from my oldest @MDAndersonNews friend @doctorpemm improving outcomes across the age spectrum for #BPDCN . An unstoppable Dept, proud to see you soar friends 💫🌠

Hagop Kantarjian,MD

@DrHKantarjian

10 months

Important, multi-disciplinary, joint pediatric/adult leukemia group effort led by our Drs @CuglievanBranko & @doctorpemm → highlighting new era of research & discovery for #BPDCN in #pediatric and #AYA patients @LeukemiaJnl @MDAndersonNews

4

33

101

1

3

15

Sapna Patel

@DrSapnaPatel

2 years

In melanoma, if KEYNOTE-054 established adjuvant pembro > placebo, and @SWOG S1404 established adjuvant pembro > Ipi or IFN, have we convinced you that #S1801 demonstrated neoadjuvant pembro > adjuvant pembro 🆒 and bulky resectable stage IIIB & up should have immunotx 1st? 🆗❗️

OncLive.com

@OncLive

2 years

According to the phase 2 SWOG S1801 trial, compared with adjuvant pembro alone, the addition of neoadjuvant pembro significantly improved EFS outcomes for pts w/ stage III-IV melanoma w/ a hazard ratio of 0.58 @DrSapnaPatel @MDAndersonNews #melsm #ESMO2022

0

2

1

4

15

Sapna Patel

@DrSapnaPatel

5 years

My 🦄, my 🦸🏼‍♀️, my inspiration 💗 Go Britta, go! 🏃‍♀️🏅

MD Anderson Cancer Center

@MDAndersonNews

5 years

“I ran after difficult conversations with doctors, family and friends, and I ran despite feeling like I wouldn’t be around much longer.” #Eyecancer survivor Britta Fortson shares how she coped with the stress of her diagnoses and treatment: @DrSapnaPatel

2

5

32

1

0

15

Sapna Patel

@DrSapnaPatel

1 year

A great meeting in NYC while my colleagues are hanging in Boston for @sitcancer , look who I ran into at @gotoPER #gotoCFS #gotoPER #CFS22 #CFS40 @Rdcarval @DrChoueiri

1

2

15

Sapna Patel

@DrSapnaPatel

2 years

Our @HemOncWomenDocs @DrBetofMDPhD @GlitzaMDPhD Wolfpack in Paris @myESMO #ESMO22 along with our #melanoma tribe 🙏🏽 (11/17)

0

2

15

Sapna Patel

@DrSapnaPatel

2 years

👀 📖‼️ Congratulations @ANaingMD @HajjarJoud

Aung Naing

@ANaingMD

2 years

We thank the authors for their contribution and Dr. Hajjar @HajjarJoud for co-editing. We believe it will provide overview in clinical immuno-oncology.

5

21

59

1

5

15

Sapna Patel

@DrSapnaPatel

7 months

We were a bit of a sitcom episode trying to take a group photo last week @SWOG #melanoma committee working group. 👨‍👩‍👧‍👦 The zoom attendees are barely visible & most in the room were caught in different moments off guard 📸 #SWOGOnc 1/4

1

2

14

Sapna Patel

@DrSapnaPatel

3 years

While certainly not the ORR seen in cutaneous melanoma, this combo allows for a standard of care option for patients and a possible control arm for future trials.

Journal of Clinical Oncology

@JCO_ASCO

3 years

Nivolumab plus ipilimumab demonstrates activity in patients with metastatic uveal melanoma #melsm #ImmunoOnc #JCO @DrSapnaPatel @MDAndersonNews

1

9

10

0

3

14

Sapna Patel

@DrSapnaPatel

5 months

✨️Just two of many reasons I feel honored to take care of patients like this: the grace of patients like Tommy Stone and the partnership with exceptional clinicians such as @GlitzaMDPhD 🥼

MD Anderson Cancer Center

@MDAndersonNews

5 months

When diagnosed with leptomeningeal disease, Tommy Stone thought he had just a few months to live. Learn how a clinical trial at MD Anderson gave him hope: @DrSapnaPatel @GlitzaMDPhD #melanoma #EndCancer

0

4

21

1

14

Sapna Patel

@DrSapnaPatel

2 years

The beautiful albeit confusing art accompanying our @CD_AACR paper reporting @SWOG S1404 randomized Ph III study results - the largest adjuvant PD1 study in #melanoma . Proud to lead this work w @KenGrossmannMD Megan Othus & @ToniRibas12 Next up..our S1404 QOL study w @DrJoeUnger

Cancer Discovery

@CD_AACR

2 years

From the March issue: Adjuvant pembrolizumab versus interferon alfa-2b or ipilimumab in resected high-risk #melanoma by @KenGrossmannMD , @ToniRibas12 et al. Megan Othus @huntsmancancer @SWOG @DrSapnaPatel @MDAndersonNews @UCLAJCCC #clinicaltrial

0

5

4

1

5

14

Sapna Patel

@DrSapnaPatel

3 years

It was a pleasure to be involved in this Team Science adjuvant trial for #melanoma published in @jitcancer . @CraigSlingluff taught me so much about vaccine compositions and immunogenicity. #jitc #melsm

Journal for ImmunoTherapy of Cancer

@jitcancer

3 years

New #JITC article: Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund’s adjuvant (IFA) for resected high-risk melanoma @DrSapnaPatel @PatrickHwuMD @CraigSlingluff

1

3

1

2

14

Sapna Patel

@DrSapnaPatel

7 months

Thank you to our fantastic @SWOG #melanoma cmte keynote speaker 👨‍🏫Olivier Michielin from U Geneva🇨🇭 - a dear colleague and 🥼👨🏽‍⚕️ expert in #oncoinformatics Looking forward to more great ideas at IMWG & @myESMO #ESMO23 4/4

0

3

14

Sapna Patel

@DrSapnaPatel

2 years

This tweet from @AndreasBracher gives *me* goosebumps! I agree that #ESMO22 was outstanding and am so grateful our @SWOG #S1801 data had an impact - ripples beyond #melanoma as #neoadjuvant ( #neoadjuvant é) has its moment with cSCC and @MyriamChalabi #NICHE -2 #Chalabiplot

Andreas Bracher

@AndreasBracher

2 years

#ESMO2022 was truly terrific! My 3 goosebumps moments 1 - @DrSapnaPatel for opening the #neoadjuvant era in #melanoma 2 - @MyriamChalabi for introducing the #ChalabiPlot 3 - @montypal for setting standards as discussant

0

5

30

0

2

14

Sapna Patel

@DrSapnaPatel

2 years

Many more great articles to come, it has been a pleasure to serve as Guest Editor for this issue @FrontOncology @FrontiersIn ... stay tuned

Frontiers - Oncology

@FrontOncology

2 years

🌟Check out the 3 most viewed articles from our Research Topic: 'Women in Skin Cancer: 2021' and read here for more 👉 Editor: @DrSapnaPatel #WomenInScience #STEM #WomenInSTEM #SkinCancer #SkinHealth 👇👇👇

1

0

2

0

3

13

Sapna Patel

@DrSapnaPatel

3 years

tfw your #wim #melanoma #icon gives you a tweet out ☺ @kmargolin is a beloved colleague and empath @SWOG @AIMatMelanoma #melsm #fbf SWOG Fall Mtg 2018

Kim Margolin

@kmargolin

3 years

Fantastic job at first (still virtual) #SWOG #melanoma committee meeting by incoming chair @drsapnapatel —lots of new protocols on horizon with great correlates. Next spring in Seattle!!

1

0

9

1

13

Sapna Patel

@DrSapnaPatel

3 years

My Alaskan Malamute got a taste of his roots

0

13

Sapna Patel

@DrSapnaPatel

2 years

@OncBrothers @rachnatshroff @CathyEngMD @MyriamChalabi @myESMO @colontown Wonderful summary & discussion! Don't forget the #melanoma practice-changing data from #ESMO22 - @SWOG #S1801 where nearly half of the 345 participants were enrolled @ community practices, @HaanenJohn 's phase III TIL trial, IMMUNED, SECOMBIT, #neoadjuvant for cuSCC, MCC data🩺

2

13

Sapna Patel

@DrSapnaPatel

3 years

Thank you @jitcancer @sitcancer for highlighting our work in #uvealmelanoma - send me FFPE and blood if you have R/NR you’d like analyzed! #melsm @MDAndersonNews

Journal for ImmunoTherapy of Cancer

@jitcancer

3 years

New #JITC article: Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy @DrSapnaPatel

0

4

10

1

3

13

Sapna Patel

@DrSapnaPatel

2 years

Quite honestly flattered & humbled☺️to represent neoadjuvant-adjuvant therapy success over standard of care adjuvant therapy approach in #melanoma on behalf of our @SWOG investigators…and in awe to be mentioned by McDermott and noted by @montypal 🤩 Please steal from #S1801 ‼️

Sumanta K. Pal, MD, FASCO

@montypal

2 years

An inspiring @KidneyCancer Keynote Lecture from #DavidMcDermott at #IKCS22 . An impressive lecture paying homage to visionaries past, present & future! @DrSapnaPatel @MyriamChalabi @TurajlicLab @LabSignoretti @kaelin_lab @DrChoueiri @brian_rini & many others showcased.

0

19

39

0

13

Sapna Patel

@DrSapnaPatel

4 years

I am certainly gifted with my career and a number of unseen victories bc of the doggedness of RBG #RIPRuthBaderGinsburg #ThankYouRBG Notorious.

NPR Politics

@nprpolitics

4 years

Justice Ruth Bader Ginsburg, Champion Of Gender Equality, Dies At 87

7K

70K

134K

0

13

Sapna Patel

@DrSapnaPatel

11 months

@ProfGLongMIA @ProfRScolyerMIA @MelanomaAus Remarkable achievement by the indomitable team of @ProfGLongMIA & @ProfRScolyerMIA !! Incredibly proud and in awe of the fortitude to make this happen in Australia 🇦🇺 @OncoAlert @SWOG #S1801

0

1

13

Sapna Patel

@DrSapnaPatel

2 years

Got 90 minutes on Sept 20? 🔜Come virtually hear institutional perspectives on #melanoma and skin cancers incl #uveal melanoma - worth it to hear evidence-based & cutting edge research in a flash, plus chance to win AirPods! 📢 🪩 @OncLive @MDAndersonNews

Hussein Tawbi, MD, PhD

@HTawbi_MD

2 years

Join me & the Melanoma Medical Oncology team @MDAndersonNews on 9/20 at 6:30pm CT for an @OncLive Skin Cancer virtual event. Expert Faculty Michael A. Davies, MD, PhD, @MKWongMDPhD , and @DrSapnaPatel @OncLiveSOSS Register:

0

2

3

0

1

13

Sapna Patel

@DrSapnaPatel

4 years

Cancer drug trials on hold amid coronavirus disruption

0

10

12

Sapna Patel

@DrSapnaPatel

2 years

Thank you @HHorinouchi for watching virtually and the insight into other immune checkpoint inhibitor responsive tumors. #neoadjuvant is prime time (and simple can be good)!

Hidehito HORINOUCHI

@HHorinouchi

2 years

S1801: Neo- vs. adjuvant pembrolizumab for stage III-IV melanoma by @DrSapnaPatel . Striking EFS benefits by neoadjuvant! Simple but highly important clinical question. Expect that it is not limited to melanoma. Direct comparison is needed in thoracic oncology. #LCSM #ESMO22

0

28

89

1

12

Sapna Patel

@DrSapnaPatel

6 years

Excellent scientific retreat yesterday @SocietyMelanoma Research meeting put on by @MRFCureOM - many updates and original research presented, including $PVCT PV-10 data and a clinical trials panel #uvealmelanoma #melsm #endcancer @MDAndersonNews

1

4

12

Sapna Patel

@DrSapnaPatel

11 months

@ProfRScolyerMIA @DrZembowicz @ProfGLongMIA Dear Richard, picking myself up from falling out of my chair reading your message. Sending you love 💞 , strength, and support from your @SWOG friends, #melanoma family, and oncology universe. May you put the miles of this journey in your rearview soon, as you did @ #GreatWall

0

12

Sapna Patel

@DrSapnaPatel

5 years

Thank you @SurvivorNetTeam Alex, Steve and @MDAndersonNews for the morning session on #melanoma #uvealmelanoma #immunotherapy and #targetedtherapy #melsm #endcancer @JenniferLitton & @Aiims1742 Jim & Pam - I know you were there, too!

0

2

12